Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BC Bud Corp WFGCF


Primary Symbol: C.BCBC Alternate Symbol(s):  BCBCF

The BC Bud Corporation is a Canadian cannabis company. It is engaged in developing recreational cannabis products and brands in the cannabis industry through licensing, contract manufacturing and joint venture agreements with licensed producers. Its offerings in branded products include The BC Bud Co flower products, edibles under the brand Canna Beans and Canna Almonds, concentrates sold as Solventless Solutions, and Buds beverages line and select lifestyle apparel. Its products include Animal Cookies, Alaskan Thunder F (ATF), HHH, Apricot Kush, Citrus Hash Plant, Mosambi, Narang Tang, Teacup, Fruitcake Kush, Oreo Kush Mint (OKM), Punch Bowl Infused, Canna Beans and Canna Almonds. Its Apricot Kush Live Rosin is an Indica leaning, full spectrum, solventless concentrate. Canna Beans are made with Belgian Callebaut Chocolate and roasted sustainable decaf coffee bean with cannabis. Fruitcake Kush offers a complex flavor profile with sweet, fruity notes and hints of vanilla and spice.


CSE:BCBC - Post by User

Comment by veteran98on Dec 13, 2020 9:20am
228 Views
Post# 32095126

RE:Let’s see where this goes

RE:Let’s see where this goesSeems ENTH.H may be getting closer to targeting a direction as the shares have getting marked up higher ... very tight share structure so it will be interesting to see what direction they take. Earlier in the year the MD&A mentioned review of acquisition opportunities to targets involved in medical entheogenics but the latest MD&A seems to have an expanded focus with the wording changed to actively seeking opportunities to seek to graduate from the NEX. 
<< Previous
Bullboard Posts